ENSC
Ensysce Biosciences, Inc.
+0.01 (+2.10%)0.46USD300K成交股數8.9M市值–本益比(近四季)2.0股價營收比-15.1%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.2M-15% | 961K-27% | 1.9M-45% | 493K+171% | 1.4M+349% | 1.3M+156% | 3.4M+685% | 182K-63% | 306K | 515K | 435K | 490K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.5M | 3.3M | 3.6M | 3.0M | 1.9M | 1.9M | 1.7M | 947K | 779K | 2.2M | 1.9M | 1.6M |
| 銷售管理費用 | 1.3M | 1.2M | 1.1M | 1.3M | 1.2M | 1.4M | 1.1M | 1.2M | 1.4M | 1.4M | 1.2M | 1.1M |
| 營業利益 | −2.6M+47% | −3.6M+81% | −2.8M-531% | −3.7M+91% | −1.8M-5% | −2.0M-38% | 645K-124% | −2.0M-15% | −1.8M | −3.2M | −2.7M | −2.3M |
| 營業利益率 | -221.3% | -370.7% | -147.8% | -758.7% | -127.6% | -149.1% | 18.9% | -1,075.6% | -602.8% | -612.7% | -621.8% | -467.7% |
| 稅後淨利 | −2.6M+48% | −3.6M+83% | −2.8M-518% | −3.7M+90% | −1.7M-44% | −1.9M-44% | 662K-125% | −2.0M-12% | −3.1M | −3.5M | −2.7M | −2.2M |
| 淨利率 | -220.8% | -370.1% | -147.0% | -756.3% | -126.4% | -147.4% | 19.4% | -1,082.4% | -1,019.4% | -680.4% | -618.0% | -456.6% |
| 稀釋 EPS | -0.20-75% | -0.52-63% | -0.51-151% | -1.29-61% | -0.79-90% | -1.39-98% | 1.00-215% | -3.35+242% | -8.21 | -66.47 | -0.87 | -0.98 |
| 稀釋股數 | 13.0M | 6.8M | 2.6M | 2.9M | 2.2M | 1.4M | 659K | 588K | 380K | 151K | 3.1M | 2.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 677K | 745K | 4.3M | 1.7M | 2.2M | 3.1M | 4.2M | 1.0M | 3.4M | 1.1M | 1.5M | 3.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 3.0M | 2.2M | 7.5M | 3.2M | 5.6M | 4.6M | 9.4M | 2.8M | 5.1M | 2.7M | 3.2M | 6.4M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 4.1M | 2.8M | 4.6M | 2.3M | 2.5M | 1.9M | 2.8M | 1.3M | 1.7M | 3.4M | 2.1M | 2.6M |
| 股東權益 | −782K | −340K | 3.2M | 1.2M | 3.4M | 3.0M | 6.9M | 1.8M | 3.7M | −323K | 1.5M | 4.1M |
| 負債比 | 137.6% | 130.9% | 61.3% | 72.5% | 45.1% | 41.0% | 29.9% | 47.1% | 32.6% | 124.0% | 64.0% | 40.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.5M+105% | – | – | – | −1.7M | – | – | −3.4M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 5.1M | -2.8% | −10.2M | -200.8% | -3.98 | −7.9M |
| FY2024 | 5.2M | +133.6% | −8.0M | -153.3% | -11.45 | – |
| FY2023 | 2.2M | -11.6% | −10.6M | -476.4% | -70.40 | – |
| FY2022 | 2.5M | -28.5% | −24.2M | -959.3% | -139.42 | – |
| FY2021 | 3.5M | -10.2% | −29.1M | -825.4% | -1.48 | – |
| FY2020 | 3.9M | – | 4.3M | 109.7% | 0.00 | – |
| FY2019 | – | – | −1.1M | –% | -0.63 | – |
| FY2018 | – | – | 2.1M | –% | -0.21 | – |